These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8054374)

  • 1. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
    Otto E; Jones-Trower A; Vanin EF; Stambaugh K; Mueller SN; Anderson WF; McGarrity GJ
    Hum Gene Ther; 1994 May; 5(5):567-75. PubMed ID: 8054374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
    Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
    Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication.
    Dang Q; Hu WS
    J Virol; 2001 Jan; 75(2):809-20. PubMed ID: 11134294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of retroviral vectors with enhanced efficiency of transgene expression.
    Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
    J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J; Reeves L; Sanburn N; Croop J; Williams DA; Cornetta K
    Virology; 2001 Mar; 282(1):186-97. PubMed ID: 11259201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
    Uchida E; Sato K; Iwata A; Ishii-Watabe A; Mizuguchi H; Hikata M; Murata M; Yamaguchi T; Hayakawa T
    Biologicals; 2004 Sep; 32(3):139-46. PubMed ID: 15536044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety considerations in vector development.
    Kappes JC; Wu X
    Somat Cell Mol Genet; 2001 Nov; 26(1-6):147-58. PubMed ID: 12465466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.
    Martineau D; Klump WM; McCormack JE; DePolo NJ; Kamantigue E; Petrowski M; Hanlon J; Jolly DJ; Mento SJ; Sajjadi N
    Hum Gene Ther; 1997 Jul; 8(10):1231-41. PubMed ID: 9215740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines.
    Scarpa M; Cournoyer D; Muzny DM; Moore KA; Belmont JW; Caskey CT
    Virology; 1991 Feb; 180(2):849-52. PubMed ID: 1989392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced integration of Moloney murine leukemia virus DNA with a mutant integration site occurs through recombination with VL30 DNA.
    Murphy JE; Goff SP
    Virology; 1994 Oct; 204(1):458-61. PubMed ID: 8091679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient replication, integration, and packaging of retroviral vectors with modified long terminal repeats containing the packaging signal.
    Joshi S; Van Brunschot A; Robson I; Bernstein A
    Nucleic Acids Res; 1990 Jul; 18(14):4223-6. PubMed ID: 2377461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
    Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
    Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.
    Paar M; Klein D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    BMC Mol Biol; 2009 Feb; 10():8. PubMed ID: 19203366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
    Chen J; Reeves L; Cornetta K
    Hum Gene Ther; 2001 Jan; 12(1):61-70. PubMed ID: 11177543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
    Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
    Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homologous recombination of copackaged retrovirus RNAs during reverse transcription.
    Stuhlmann H; Berg P
    J Virol; 1992 Apr; 66(4):2378-88. PubMed ID: 1372369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
    Parthasarathi S; Varela-Echavarría A; Ron Y; Preston BD; Dougherty JP
    J Virol; 1995 Dec; 69(12):7991-8000. PubMed ID: 7494312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
    J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.